Projects overview

Sort by


Toggle all information

IoF2020 | Internet of Food and Farm 2020

01-01-2017

-

31-03-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.0. Cross-cutting call topics
H2020-IOT-2016
IoT-01-2016 Large Scale Pilots

PHArA-ON | Pilots for Healthy and Active Ageing

01-12-2019

-

30-11-2024

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.1. Active ageing, independent and assisted living
H2020-SC1-FA-DTS-2018-2
DT-TDS-01-2019 Smart and healthy living at home

ADiRaS | Alzheimer’s Disease Diagnosis by Spectroscopy. Accurate and Non-Invasive Medical Device for the Diagnosis of Early Stage Alzheimer's Disease.

01-07-2015

-

31-10-2015

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

EPICHECK | Detection of Various Cancer Types for Screening and Diagnosis through Blood Samples with Epigenetic Biomarkers Panels

01-10-2015

-

31-03-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

AgeingatWork | Smart, Personalized and Adaptive ICT Solutions for Active, Healthy and Productive Ageing with enhanced Workability

01-01-2019

-

30-06-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.1. Active ageing, independent and assisted living
H2020-SC1-DTH-2018-1
SC1-DTH-03-2018 Adaptive smart working and living environments supporting active and healthy ageing
H2020-EU.3.1.4.2. Individual awareness and empowerment for self-management of health
H2020-SC1-DTH-2018-1
SC1-DTH-03-2018 Adaptive smart working and living environments supporting active and healthy ageing

COPCAR | Heart monitoring and early assistance in high risk crisis without patient intervention (COPCAR)

01-04-2016

-

30-09-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

COMPAR-EU | Comparing effectiveness of self-management interventions in 4 high priority chronic diseases in Europe

01-01-2018

-

31-12-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2017-Two-Stage-RTD
SC1-PM-10-2017 Comparing the effectiveness of existing healthcare interventions in the adult population

IMPACT DIABETES B2B | Implementation Action to prevent Diabetes from Bump 2 Baby (IMPACT DIABETES B2B): a low-resource system of care intervention for appropriate gestational weight gain and improved postnatal outcomes

01-01-2020

-

30-06-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-19-2019 Implementation research for maternal and child health

SUNI-SEA | Scaling-up NCD Interventions in South East Asia

01-01-2019

-

30-06-2023

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2018-Single-Stage-RTD
SC1-BHC-16-2018 Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes

NISCI | Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European clinical proof of concept trial

01-01-2016

-

30-06-2023

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2015-single-stage_RTD
PHC-15-2015 Clinical research on regenerative medicine

PEPPER | Patient Empowerment through Predictive PERsonalised decision support

01-02-2016

-

31-03-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.0. Cross-cutting call topics
H2020-PHC-2015-single-stage
PHC-28-2015 Self management of health and disease and decision support systems based on predictive computer modelling used by the patient him or herself

EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847

01-12-2014

-

30-11-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2)
H2020-EU.3.1.7.0. Cross-cutting call topics
H2020-JTI-IMI2-2014-02-single-stage
IMI2-2014-02-04 Deployment and compliance of vaccination regimens

ADAPTED | Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975

01-10-2016

-

30-09-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2)
H2020-EU.3.1.7.0. Cross-cutting call topics
H2020-JTI-IMI2-2015-05-two-stage
IMI2-2015-05-06 From ApoE biology to validated Alzheimer’s disease targets

Tomo-FPS | Tomosynthesis is a low-dose alternate to has CT already transformed Breast Imaging, our vision is to reduce the costs, further enhance sensitivity and reduce dose, and transform portability.

01-10-2015

-

31-10-2015

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices

REPO-TRIAL | An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes

01-02-2018

-

31-01-2024

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.5. Methods and data
H2020-EU.3.1.5.0. Cross-cutting call topics
H2020-SC1-2017-CNECT-2
SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products
Powered by Chris Decubber BV